TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3788226

Group type: EXPERIMENTAL
Intervention: FCE 20700, 500 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FCE 20700, 1500 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FCE 20700, 500 micrograms and 1500 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FCE 20700, 250 micrograms t.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FCE 20700, 750 micrograms t.i.d.
Number of subjects: 0
Study: 29724663

Group type: EXPERIMENTAL
Intervention: High-dose venlafaxine (up to 300 mg/day) plus problem-solving therapy (PST) for 10 weeks
Number of subjects: 227

Group type: COMPARATOR
Intervention: High-dose venlafaxine with supportive management for 10 weeks
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Both interventions (PST and supportive management)
Number of subjects: 227
Study: 30641622

Group type: EXPERIMENTAL
Intervention: Wuling Powder (WP) combined with ventriculoperitoneal shunt surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo decoction combined with ventriculoperitoneal shunt surgery
Number of subjects: 56
Study: 23792312

Group type: EXPERIMENTAL
Intervention: Polyvalent mechanical bacterial lysate (PMBL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23401480

Group type: EXPERIMENTAL
Intervention: High power condition
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low power condition
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control power condition
Number of subjects: 3
Study: 19942604

Group type: EXPERIMENTAL
Intervention: Tissue Doppler E/E' ratio
Number of subjects: 980

Group type: COMPARATOR
Intervention: Conventional echocardiography
Number of subjects: 980
Study: 19000603

Group type: EXPERIMENTAL
Intervention: 30% nitrous oxide inhalation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no nitrous oxide)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Additional music during sedation
Number of subjects: 26
Study: 15728057

Group type: EXPERIMENTAL
Intervention: Frakefamide (FF) 1.22 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine (M-large) 0.43 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine (M-small) 0.11 mg/kg
Number of subjects: 12
Study: 12856052

Group type: EXPERIMENTAL
Intervention: Mebendazole (500 mg)
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Levamisole (40 or 80 mg)
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Combined treatment with mebendazole and levamisole
Number of subjects: 914

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 914
Study: 10565560

Group type: EXPERIMENTAL
Intervention: Cow's milk formula (CMF)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Human milk (HM)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Casein hydrolysate formula (CHF)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: All feeding groups (CMF, HM, CHF)
Number of subjects: 129
Study: 8604417

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (Atrovent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pneumococcal and influenza vaccinations
Number of subjects: 0
Study: 1715152

Group type: EXPERIMENTAL
Intervention: Co-sleeping (102 babies)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Crib care (101 babies)
Number of subjects: 203
Study: 7153946

Group type: EXPERIMENTAL
Intervention: VT (10 sessions)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: VT (5 sessions) and CT (5 sessions)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CT (10 sessions)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CT (5 sessions) and VT (5 sessions)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Waiting control
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: EG-1a (VT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: EG-11a (CT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cognitive training groups
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 16
Study: 31030379

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (660 nm, 100 mW, 2 J, 66.66 J/cm2, 3.3 W/cm2, 20 s of irradiation, punctual, and continuous mode)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no laser treatment)
Number of subjects: 80
Study: 26998803

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 193
Study: 27220593

Group type: EXPERIMENTAL
Intervention: Pulmonary artery pressure-guided management (treatment group)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (symptoms and daily weights alone)
Number of subjects: 245
Study: 25591638

Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Control (no cytoflavin)
Number of subjects: 1450
Study: 24761313

Group type: EXPERIMENTAL
Intervention: Experimental diet containing eicosapentaenoic acid (EPA), gamma‐linolenic acid (GLA), docosahexaenoic acid, and antioxidants (n=9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isonitrogenous, isocaloric standard diet (n=8)
Number of subjects: 17
Study: 19811949

Group type: EXPERIMENTAL
Intervention: 3 min rest interval (G3)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5 min rest interval (G5)
Number of subjects: 36

Group type: COMPARATOR
Intervention: 1 min rest interval (G1)
Number of subjects: 36
Study: 17968976

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16192511

Group type: EXPERIMENTAL
Intervention: 3 mL anesthetic solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 mL anesthetic solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (3 mL and 5 mL)
Number of subjects: 0
Study: 14599236

Group type: EXPERIMENTAL
Intervention: Hippocampal recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MTLC familiarity signal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations of target-lure similarity and interference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial versus complete hippocampal lesions
Number of subjects: 0
Study: 10962319

Group type: EXPERIMENTAL
Intervention: Treatment (exact intervention not specified)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 247
Study: 8994123

Group type: EXPERIMENTAL
Intervention: Thalamic hemorrhages
Number of subjects: 43

Group type: COMPARATOR
Intervention: Putaminal hemorrhages
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 43
Study: 1309678

Group type: EXPERIMENTAL
Intervention: OK-432
Number of subjects: 53

Group type: COMPARATOR
Intervention: mitomycin C
Number of subjects: 53
Study: 3912974

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (ACV)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 31592875

Group type: EXPERIMENTAL
Intervention: Home hand strength focused exercise program (from 2 to 6 weeks after injury)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Finger range of motion exercises (control group)
Number of subjects: 52
Study: 30054467

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0
Study: 27196464

Group type: EXPERIMENTAL
Intervention: Sonolysis during cardiac surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no sonolysis)
Number of subjects: 120
Study: 25140587

Group type: EXPERIMENTAL
Intervention: High-intensity massage
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low-intensity massage
Number of subjects: 29
Study: 22276996

Group type: EXPERIMENTAL
Intervention: Active nicotine patch (21-mg)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study: 20627247

Group type: EXPERIMENTAL
Intervention: 4-month training program in HCh
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4-month training program in NL
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise program in HCh
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise program in NL
Number of subjects: 40
Study: 17560421

Group type: EXPERIMENTAL
Intervention: Current medical therapies for adult CD and UC
Number of subjects: 0
Study: 15863645

Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0
Study: 11490060

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9114777

Group type: EXPERIMENTAL
Intervention: Digitalis with acebutolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Digitalis without acebutolol
Number of subjects: 0
Study: 1438105

Group type: EXPERIMENTAL
Intervention: Benfluorex (B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin (M)
Number of subjects: 0
Study: 4065432

Group type: EXPERIMENTAL
Intervention: Good metabolic control (median blood glucose 4.7 mmol/L)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Poor metabolic control (median blood glucose 16.3 mmol/L)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Poor metabolic control
Number of subjects: 8
Study: 29621947

Group type: EXPERIMENTAL
Intervention: Pitch/Timbre group (melodic contour identification training using computer software)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Music Therapy group (face-to-face group exercises including rhythm perception, musical speech perception, music perception, singing, vocal emotion identification, and music improvisation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (group nonmusic activities such as writing, cooking, and woodworking)
Number of subjects: 0
Study: 27281084

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone 5 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous dexamethasone 5 mg
Number of subjects: 100
Study: 23821970

Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina ceramic bearings
Number of subjects: 116

Group type: COMPARATOR
Intervention: Metal-on-conventional polyethylene
Number of subjects: 116
Study: 21122269

Group type: EXPERIMENTAL
Intervention: Rességuier method (RM)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Observational Group (OG)
Number of subjects: 41
Study: 18698266

Group type: EXPERIMENTAL
Intervention: Anxious participants (n = 101)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Healthy youths (n = 51)
Number of subjects: 101
Study: 16603748

Group type: EXPERIMENTAL
Intervention: Multiple-family group intervention (26 sessions over 12 months)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 14644293

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 202

Group type: COMPARATOR
Intervention: Focused attention
Number of subjects: 202

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 202
Study: 10941887

Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Field (PEMF) therapy, n = 22
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Direct Current (DC) electrical stimulation, n = 17
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group, n = 22
Number of subjects: 61
Study: 8937760

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (desogestrel+ethinyloestradiol)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (levonorgestrel and ethinyloestradiol)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (non-pregnant women not using contraceptives)
Number of subjects: 19
Study: 1576638

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (n = 11)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Potassium chloride (n = 12)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 20
Study: 3096681

Group type: EXPERIMENTAL
Intervention: Diazepam (20 mg) + Methadone (100% of maintenance dose)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diazepam (40 mg) + Methadone (100% of maintenance dose)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diazepam (20 mg) + Methadone (150% of maintenance dose)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diazepam (40 mg) + Methadone (150% of maintenance dose)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo + Methadone (100% of maintenance dose)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo + Methadone (150% of maintenance dose)
Number of subjects: 5
Study: 29222891

Group type: EXPERIMENTAL
Intervention: Glucose (50 g/278 mL, p.o.) 2 h before anaesthesia induction
Number of subjects: 23

Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 23
Study: 27219115

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (once daily for 5 consecutive days starting on postoperative day 1, at 16 acupoints)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonacupuncture (no treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 10
Study: 25481809

Group type: EXPERIMENTAL
Intervention: Various OA treatments (pharmacological and non-pharmacological)
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Physical therapy for knee OA
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Physical therapy for hip OA
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Use of knee brace with metal supports
Number of subjects: 537
Study: 22284848

Group type: EXPERIMENTAL
Intervention: Osteoarthritis of the Knee Self‐Management Program (OAK)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (6-month waiting period)
Number of subjects: 146
Study: 20451804

Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR) measurement by transthoracic Doppler echocardiography (TTDE)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: CFR value < 2.0
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: CFR assessment in left anterior descending coronary artery
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: CFR assessment in right coronary artery
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: CFR assessment in left circumflex coronary artery
Number of subjects: 175
Study: 18025524

Group type: EXPERIMENTAL
Intervention: Peptidic erythropoiesis receptor agonist at doses of 0.025, 0.05, and 0.1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peptidic erythropoiesis receptor agonist
Number of subjects: 0
Study: 18468569

Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagnostic laparoscopy
Number of subjects: 0
Study: 15886445

Group type: EXPERIMENTAL
Intervention: Right lateral decubitus position
Number of subjects: 0
Study: 11676992

Group type: EXPERIMENTAL
Intervention: Sustained maximal voluntary isometric contraction (MVIC) of elbow flexors, knee extensors, and ankle dorsiflexors for 30 seconds
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal control subjects performing the same MVIC
Number of subjects: 54
Study: 9460311

Group type: EXPERIMENTAL
Intervention: Induction with intravenous oxytocin
Number of subjects: 5041

Group type: EXPERIMENTAL
Intervention: Induction with vaginal prostaglandin E2 gel
Number of subjects: 5041

Group type: COMPARATOR
Intervention: Expectant management followed by induction with oxytocin
Number of subjects: 5041

Group type: COMPARATOR
Intervention: Expectant management followed by induction with prostaglandin E2 gel
Number of subjects: 5041

Group type: EXPERIMENTAL
Intervention: Induction groups (both types)
Number of subjects: 5041

Group type: COMPARATOR
Intervention: Expectant management groups
Number of subjects: 5041
Study: 8194610

Group type: EXPERIMENTAL
Intervention: Vaginal ultrasound and serum hCG determinations performed between 20 and 30 days after conception.
Number of subjects: 0
Study: 3317352

Group type: EXPERIMENTAL
Intervention: 20 micrograms dose per injection
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: 40 micrograms dose per injection
Number of subjects: 314
Study: 12444268

Group type: EXPERIMENTAL
Intervention: Canine lacebacks
Number of subjects: 35

Group type: COMPARATOR
Intervention: No canine lacebacks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Canine lacebacks and No canine lacebacks
Number of subjects: 35
Study: 31424302

Group type: EXPERIMENTAL
Intervention: Electric calendar intervention (used by 15 participants)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No intervention (control group with 12 participants)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Electric calendar intervention
Number of subjects: 27
Study: 30202927

Group type: EXPERIMENTAL
Intervention: 10-week group workshop on cognitive-behavioral coping skills
Number of subjects: 92

Group type: COMPARATOR
Intervention: Enhanced usual care (self-help materials for BP reduction and physician referral)
Number of subjects: 92
Study: 27283332

Group type: EXPERIMENTAL
Intervention: Triple DMARD therapy with glucocorticoid bridging
Number of subjects: 159

Group type: COMPARATOR
Intervention: Methotrexate monotherapy with glucocorticoid bridging
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Tapering csDMARDs
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Tapering bDMARDs
Number of subjects: 159
Study: 24828091

Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy
Number of subjects: 1649
Study: 22885329

Group type: EXPERIMENTAL
Intervention: ALFSG index (based on M30 levels and clinical variables)
Number of subjects: 250

Group type: COMPARATOR
Intervention: King's College criteria (KCC)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Model for End Stage Liver Disease (MELD)
Number of subjects: 250
Study: 20117031

Group type: EXPERIMENTAL
Intervention: AGHO (hyperoxygenated fatty acids)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Mepentol (control)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Comparison of AGHO and Mepentol
Number of subjects: 148
Study: 19186857

Group type: EXPERIMENTAL
Intervention: Root canal therapy bypassing broken instruments (test group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy (conventional therapy group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not bypassing broken instruments)
Number of subjects: 32
Study: 16438239

Group type: EXPERIMENTAL
Intervention: Twisting strength measured with a device
Number of subjects: 77
Study: 14610985

Group type: EXPERIMENTAL
Intervention: CATCH program implemented in 18 Title I pilot schools
Number of subjects: 108
Study: 10506877

Group type: EXPERIMENTAL
Intervention: Pristinamycin, 2 g/d for 8 days
Number of subjects: 310

Group type: COMPARATOR
Intervention: Cefuroxime axetil, 500 mg/d
Number of subjects: 310
Study: 7493787

Group type: EXPERIMENTAL
Intervention: Immediate active exercises
Number of subjects: 62

Group type: COMPARATOR
Intervention: Immobilization in a plaster
Number of subjects: 62
Study: 1951871

Group type: EXPERIMENTAL
Intervention: Low-dose heparin subcutaneously
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) intravenously
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 97
Study: 6782606

Group type: EXPERIMENTAL
Intervention: Secobarbital 1.47 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secobarbital 2.94 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 0
Study: 31719552

Group type: EXPERIMENTAL
Intervention: 30 days of 6 degrees head-down tilt bed rest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29522529

Group type: EXPERIMENTAL
Intervention: Postal intervention (pedometer, handbooks, PA diaries)
Number of subjects: 1231

Group type: EXPERIMENTAL
Intervention: Nurse support intervention (pedometer, handbooks, PA diaries)
Number of subjects: 1231

Group type: EXPERIMENTAL
Intervention: Nurse support intervention (PACE-Lift)
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Control group (PACE-UP)
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Control group (PACE-Lift)
Number of subjects: 1231
Study: 26790144

Group type: EXPERIMENTAL
Intervention: IFN 13 months
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: IFN 25 months
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Stage IIB/III-N1 with ulcerated melanoma IFN 13 months
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Stage IIB/III-N1 with ulcerated melanoma IFN 25 months
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Stage IIB/III-N1 with ulcerated melanoma Observation
Number of subjects: 1388
Study: 24820290

Group type: EXPERIMENTAL
Intervention: Motion-aftereffect (MAE) induced eye movements
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAE induced eye movements
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Afternystagmus (ASOKN)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-brightness stimuli
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-brightness stimuli
Number of subjects: 17
Study: 22648445

Group type: COMPARATOR
Intervention: Anterior colporrhaphy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Soft polypropylene mesh (GYNEMESH*PS, Gynecare, Ethicon, France)
Number of subjects: 44
Study: 20667262

Group type: EXPERIMENTAL
Intervention: Meditation program (mindfulness)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 18591361

Group type: EXPERIMENTAL
Intervention: Print and telephone intervention
Number of subjects: 966

Group type: COMPARATOR
Intervention: Contact comparison group
Number of subjects: 966
Study: 15795697

Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: IPF patients
Number of subjects: 84

Group type: COMPARATOR
Intervention: IPF sera
Number of subjects: 84
Study: 15530692

Group type: EXPERIMENTAL
Intervention: Connaught high titer vaccine (CN)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Meningococcal A + C vaccine (MEN)
Number of subjects: 111